ArticleAIDS (London, England)2026
Reproductive stage and other risk factors associated with intimate partner violence: a multisite study of women with HIV in the United States.
Article in AIDS (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From systems that harm to systems that heal: ending HIV requires confronting gender-based violence across the life course.AIDS (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveThe 2025 US National HIV/AIDS Strategy identifies intimate partner violence (IPV) as a key social determinant in the HIV response. Women with HIV (WHIV) face heightened IPV risk, especially during pregnancy. We evaluated the associations between reproductive stage, structural risk factors and past-year IPV among WHIV in the United States.
designWe conducted a cross-sectional analysis using 2022-2025 baseline survey data from the HOPE prospective cohort of WHIV across 14 sites in nine US states/territories.
methodsThe outcome was past-year experience of physical, sexual, or psychological IPV or reproductive coercion. Reproductive stage was categorized as nulliparous, postpartum, parous/nonpregnant, and pregnant. We used generalized estimating equations to estimate prevalence ratios for the association of each risk factor with IPV. We fit separate models for each risk factor, adjusting for age, race, education, income, marital status, and study region. We assessed the impact of nonresponse to IPV questions.
resultsAmong 742 participants, 538 (79%) had complete data on past-year IPV. Over one in four WHIV (26.4%) had experienced past-year IPV. Pregnant women had four times the prevalence of reproductive coercion [(aPR = 4.0; 95% confidence interval (95% CI): 1.7-9.5] and 1.7 times (aPR = 1.7; 95% CI: 1.3-2.3) the prevalence of psychological IPV, compared to parous/nonpregnant women. Early sexual debut (aPR = 2.3; 95% CI:1.2-4.5), transactional sex (aPR = 2.1; 95% CI:1.3-3.4), drug use (aPR = 1.7; 95% CI:1.1-2.6), and adverse childhood experiences (aPR = 1.2; 95% CI:1.1-1.2) were associated with past-year IPV.
conclusionIPV is prevalent among WHIV, especially during pregnancy. Policies should prioritize comprehensive contraceptive access and IPV screening to address the intersecting epidemics of IPV and HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.